Growth Metrics

Phibro Animal Health (PAHC) Receivables - Net (2016 - 2026)

Phibro Animal Health has reported Receivables - Net over the past 13 years, most recently at $215.9 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 12.56% year-over-year to $215.9 million; the TTM value through Dec 2025 reached $215.9 million, up 12.56%, while the annual FY2025 figure was $228.0 million, 33.39% up from the prior year.
  • Receivables - Net for Q4 2025 was $215.9 million at Phibro Animal Health, down from $217.9 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $228.0 million in Q2 2025 and troughed at $135.6 million in Q1 2021.
  • A 5-year average of $167.5 million and a median of $158.7 million in 2022 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: fell 10.55% in 2021 and later skyrocketed 35.53% in 2025.
  • Year by year, Receivables - Net stood at $142.5 million in 2021, then rose by 6.55% to $151.8 million in 2022, then decreased by 0.79% to $150.6 million in 2023, then grew by 27.33% to $191.8 million in 2024, then rose by 12.56% to $215.9 million in 2025.
  • Business Quant data shows Receivables - Net for PAHC at $215.9 million in Q4 2025, $217.9 million in Q3 2025, and $228.0 million in Q2 2025.